Friday's guilty plea and sentencing in Boston U.S. District Court was for illegally marketing the company's epilepsy drug Topamax for unapproved uses, the FDA said.
The government said Ortho-McNeil promoted Topamax for psychiatric uses, but the FDA never approved the drug to treat any psychiatric disorders.
An affiliate of Ortho-McNeil called Ortho-McNeil-Janssen Pharmaceuticals Inc.
will pay $75.3 million to resolve related civil allegations under the False Claims Act.
Orth-McNeil is a division of Johnson & Johnson Inc.
Copyright 2010 United Press International